An observational study in Opioid-use Disorder, Overdose of Opiate and Patient Participation, sponsored by Yale University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-16.
Sponsored by Yale University · Observational
The goal of the project is to build a clinical data research infrastructure that will begin to enhance capacity to use electronic health record (EHR) data and patient reported outcomes measures (PROs) to conduct opioid related research in emergency departments (EDs). 200 adult patients with a history of non-medical opioid use, opioid use disorder, or acute opioid overdose will be enrolled and will be asked to complete three PRO surveys (baseline, 3 days post ED discharge, and 30 days post discharge).
1,472 studies on the registry are indexed under Opioid-Related Disorders; 290 are open to participants now.
This study's enrollment of 101 is below the median of 129 across 184 observational studies indexed under Opioid-Related Disorders.
Browse Opioid-Related Disorders studies →Yale University is the lead sponsor of 1,770 studies on the registry; 294 are open to participants now.
Of its 221 completed or terminated interventional studies of FDA-regulated products, 129 (58%) have results posted.
Counted across the registry records on this site, refreshed daily.
The study population consists of adult ED patients with OUD or non-medical opioid use, or those who are being treated for opioid overdose.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This study does not include a drug, test, behavioral or medical procedure intervention; participants will be asked to complete three surveys
Willingness to share EHR data with researchers
The proportion of people who qualify for study criteria and enroll in the study
Time frame: once: at screening and enrollment
Electronic survey response
Response rate to patient reported outcomes via electronic follow-up survey
Time frame: once: 3 day follow-up survey
Treatment Effectiveness Assessment
Treatment Effectiveness Assessment (TEA) elicits patient responses that help the patient and the clinician quickly gauge patient progress in treatment and in recovery, according to the patients' sense of what is important within four domains (substance use, health, lifestyle, and community) established by prior research
Time frame: once: 3 day follow-up survey
Treatment Effectiveness Assessment
Treatment Effectiveness Assessment (TEA) elicits patient responses that help the patient and the clinician quickly gauge patient progress in treatment and in recovery, according to the patients' sense of what is important within four domains (substance use, health, lifestyle, and community) established by prior research
Time frame: once: 30 day follow-up survey
ED patients prescribed opioid use disorder medication
The proportion of participants prescribed opioid use disorder medication as part of routine emergency medical care
Time frame: once: 3 day follow-up survey
ED patients prescribed opioid use disorder medication
The proportion of participants prescribed opioid use disorder medication as part of routine emergency medical care
Time frame: once: 30 day follow-up survey
ED patients referred to substance use disorder treatment
The proportion of participants referred for substance use disorder treatment as part of routine emergency medical care
Time frame: once: 3 day follow-up survey
Patients enrolling in substance use disorder treatment
The proportion of participants referred for substance use disorder treatment who enroll in substance use disorder treatment
Time frame: once: 30 day follow-up survey
Patients filling opioid use disorder prescriptions
The proportion of participants prescribed opioid use disorder medication who fill the opioid use disorder prescription
Time frame: once: 3 day follow-up survey
Patients filling opioid use disorder prescriptions
The proportion of participants prescribed opioid use disorder medication who fill the opioid use disorder prescription
Time frame: once: 30 day follow-up survey
Lost-to-follow-up
Lost-to-follow-up rates
Time frame: Up to 5 months
Electronic survey response
Response rate to patient reported outcomes via electronic follow-up survey
Time frame: once: 30 day follow-up survey
PDFs hosted by the registry, ClinicalTrials.gov.
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.